Filing Details
- Accession Number:
- 0001144204-15-027951
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-06 16:12:42
- Reporting Period:
- 2015-04-24
- Filing Date:
- 2015-05-06
- Accepted Time:
- 2015-05-06 16:12:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1175151 | Cytosorbents Corp | CTSO | Surgical & Medical Instruments & Apparatus (3841) | 980373793 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1368151 | Vincent Capponi | C/O Cytosorbents Corporation 7 Deer Park Drive, Suite K Monmouth Junction NJ 08852 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-04-24 | 4,000 | $0.88 | 20,724 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-04-24 | 4,000 | $7.50 | 16,724 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2015-04-24 | 4,000 | $0.00 | 4,000 | $0.88 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 80,000 | 2018-06-25 | No | 4 | M | Direct |
Footnotes
- Stock option exercise and open market sale conducted pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- This option has been adjusted to reflect the twenty-five-for-one (25:1) reverse split of the common stock of CytoSorbents Corporation that occurred on December 3, 2014.
- The number of shares of common stock held by the reporting person has been reduced to reflect the twenty-five-for-one (25:1) reverse split described above.
- This option vested and became exercisable as to 25% of the shares on each of June 25, 2008, June 25, 2009, June 25, 2010 and June 25, 2011.
Billionaire Hedge Funds
